Zixin Pharmaceutical is now a state-owned enterprise, and it acquired state-owned assets. In 2001, the state-owned enterprise was restructured and bought out its seniority. Later, the state-owned assets were acquired and it became a state-owned holding.
1. Company Highlights:
Advantages: The company's "Zixin" trademark is a well-known trademark in China and a famous trademark in Jilin Province. The company has been rated as "China Pharmaceutical Industry Quality Guidance Unit" and "Jilin The best word-of-mouth unit among the people of the province." "No counterfeit unit in China's pharmaceutical industry" AAA-level Chinese credit enterprise. People's reputation and loyalty are very high, and it has established a good medical brand image in the pharmaceutical industry. The company's "Zixin Ginseng" brand has certain advantages in the industry. In 2013, ginseng fruit and vegetable fermented beverages, fresh ginseng honey slices, and red ginseng and red date solid beverages obtained the "Changbai Mountain Ginseng" brand product certification; on January 11, 2015, the fifth annual international food safety summit was held, and the company's flagship ginseng bile The beverage "Shenhuxi" was awarded the designated drink by the Global Food Safety Forum.
2. Industrial hemp has been deployed for a long time
At the same time, the company's industrial hemp industry is also a hot spot in the current capital market. According to relevant announcements, the company's wholly-owned subsidiary Fytagoras (hereinafter referred to as FG) in the Netherlands signed an "Industrial Hemp Cooperation Research Agreement" with the Jilin Academy of Agricultural Sciences in January this year. The two parties will jointly carry out industrial hemp research and development. Plans Complete hemp varieties with a CBD content of 10 or more. In addition, in order to more effectively support the rapid introduction of industrial hemp technology into China, the company established Jilin Zixin Hemp R&D Co., Ltd. in Liuhe County in April, aiming to introduce FG's advanced technology in the field of industrial hemp into China and promote it as soon as possible. The company’s layout in the domestic industrial hemp field. On May 21, Zixin Pharmaceutical announced the progress of industrial hemp, saying that FG’s industrial hemp expert team simulated China’s environment and screened for the first time for relatively high CBD content (CBD content 5~22) and relatively low THC content (THC There are more than 20 kinds of industrial hemp and fiber hemp seeds with a content of less than 0.3). The earliest introduced hemp seeds were determined to be FG029070002, which is fibrous hemp with a CBD content of about 7 and a THC content of less than 0.3.
In addition, the gross profit margin of Zixin Pharmaceutical’s ginseng products is unusually low. Revenue and profits grew so much in the second quarter that it's doubtful. Some people also questioned that Zixin Pharmaceutical’s ginseng sales did not go through the circulation process. The company probably sold its own ginseng to itself. Not only that, the report also pointed out that companies were hoarding ginseng and waiting for prices to rise, causing the company's financial situation to deteriorate.